Patient Guide: A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 33 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05071300
Status: ACTIVE_NOT_RECRUITING
Condition: Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Phase: PHASE3

Find a Study Location Near You

This study is available at 33 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Scottsdale, Arizona
  • Indianapolis, Indiana
  • Baltimore, Maryland
  • • And 30 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily